Teva Pharmaceutical Industries

Latest Stories

Teva chief reports ‘strong progress’ in restructuring plan

By JOSEF FEDERMAN - Associated Press

Drugmaker to pay Mississippi $33 million in pricing lawsuit

Associated Press

FILE - In this April 26, 2017, file photo, Oklahoma Attorney General Mike Hunter speaks at a news conference in Oklahoma City. Oklahoma is one of at least 13 states that have filed lawsuits against drugmakers, alleging fraudulent marketing of drugs that fueled the opioid epidemic. Hunter says a judge has granted his request for a May 28, 2019, trial date for the lawsuit against Purdue Pharma, Allergan, Janssen Pharmaceuticals, Teva Pharmaceuticals and several of their subsidiaries. (AP Photo/Sue Ogrocki, File)

1st trial date set in state lawsuit over opioid epidemic

By KEN MILLER - Associated Press

NY settles probe of generic drug manufacturers

Associated Press

Birth control pill available to girls hits store shelves

By Tom Howell Jr. and - The Washington Times

Defective generic pill revives quality concerns

By MATTHEW PERRONE - Associated Press

FDA says Teva antidepressant is ineffective

By MATTHEW PERRONE - Associated Press

Economy Briefs: Teva Pharma discloses bribery investigation

By THE WASHINGTON TIMES

Teva Pharma discloses SEC bribery investigation

By ASSOCIATED PRESS - Associated Press

HHS says no to over-the-counter morning-after pill

By LAURAN NEERGAARD - Associated Press

US: No to over-the-counter morning-after pill

By LAURAN NEERGAARD - Associated Press

Kathleen Sebelius, secretary of health and human services (AP Photo/Charles Dharapak)

HHS: Morning-after pill can’t be sold over counter

By Lauren Neergaard - Associated Press

FDA debates over-the-counter morning-after pill

By ASSOCIATED PRESS - Associated Press